Jill McConnell

Jill Gicking McConnell is the Chief Financial Officer of Fortrea (Nasdaq: FTRE). She has served in this position since Fortrea’s launch as an independent company in July 2023 following its spinoff from Labcorp (NYSE: LH). 

Jill has more than 25 years of financial leadership in healthcare, driving growth and margin expansion as well as delivering global change and transformation projects while working in the U.S., U.K. and Ireland. Jill joined Labcorp as Chief Financial Officer of Labcorp Drug Development in 2018 until assuming the role at Fortrea. She most recently led the project that executed the spinoff of Fortrea from Labcorp. Previously, Jill held increasingly senior financial roles at GSK (LSE/NYSE: GSK), spanning the pharmaceutical lifecycle over almost 19 years. Her most recent position at GSK was Senior Vice President and Chief Financial Officer of ViiV Healthcare, a joint venture between GSK, Pfizer and Shionogi. Prior to GSK, Jill qualified as a Certified Public Accountant, primarily with PwC. 

Jill has an MBA in Health and Medical Services Administration from Saint Joseph’s University and two bachelor’s degrees in Management and French from Gettysburg College. In addition to financial leadership, Jill is committed to employee engagement and has served as executive sponsor to several employee resource groups, both at Labcorp and GSK. In 2023, Jill was named as a Luminary by the Healthcare Businesswomen’s Association.